Year: 2021

At 22.2% CAGR, Next-Generation Sequencing Market Size [2021-2028] | To Reach USD 31,411.3 Million

Written by Customer Service on December 14, 2021. Posted in Mergers And Acquisitions.

Key Companies in Next-Generation Sequencing Market are Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., QIAGEN, BGI, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., PierianDx Pune, India, Dec. 14, 2021 (GLOBE NEWSWIRE) — The global next-generation sequencing market size is expected to gain momentum by reaching USD 31,411.3 million by 2026 while exhibiting a CAGR of 22.2% between 2019 to 2026. In its report titled “Next Generation Sequencing Market, 2019-2026.”, Fortune Business Insights mentions that the market stood at USD 6,335.2 million in 2018. The rising demand for cost-effective and accurate DNA sequencing to treat genetic diseases is expected to drive the market. Moreover, the launch of several genomic projects in countries such as Qatar and the U.K with able support...

Autism Spectrum Disorder Therapeutics Market Size [2021-2028] | is Expected to be Worth USD 5.15 Billion

Written by Customer Service on December 14, 2021. Posted in Mergers And Acquisitions.

Autism Spectrum Disorder Therapeutics Market Key Companies Analyzed in this Report are Otsuka Holdings Co. Ltd. (Tokyo, Japan), Johnson & Johnson Services, Inc. (New Jersey, U.S.), AstraZeneca (Cambridge, U.K.), Pfizer Inc. (New York, U.S.), Allergan (Dublin, Ireland), Q BioMed Inc (New York, U.S.), Hopebridge, LLC. (Indiana, U.S.), Eli Lilly and Company (Indiana, U.S.) Pune, India, Dec. 14, 2021 (GLOBE NEWSWIRE) — The global Autism Spectrum Disorder Therapeutics market size is expected to be worth USD 5.15 billion by 2028. The market size was USD 3.62 billion in 2020 and USD 3.78 billion in 2021. The market is further projected to grow at a CAGR of 4.5% during the forecast period of 2021-2028. This information is provided by Fortune Business Insights™, in its report, titled, “Autism Spectrum Disorder Therapeutics Market,...

Juva Life Expands WIRB-Approved Cannabis Patient Registry Study

Written by Customer Service on December 14, 2021. Posted in Public Companies.

Company launches first U.S wide cannabis registry for Critical Research on How Cannabis Can Improve Public Health REDWOOD CITY, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life sciences portfolio company with operations in cannabis production and distribution as well as pharmaceutical research and development, announced today that the Company is currently seeking qualified participants for their WCG IRB (Puyallup, WA)-approved cannabis patient registry. The IMPACT Registry, which is listed on clinicaltrials.gov, seeks to amass one of the world’s largest data sets of real world clinical evidence on the potential health benefits of cannabis, which will be used in clinical research programs in the future. As a recognized leader at the...

Proactive news headlines including Northern Minerals, Sovereign Metals, Nova Minerals and Kingston Resources

Written by Customer Service on December 14, 2021. Posted in Mergers And Acquisitions.

Sydney, Dec. 14, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Northern Minerals Ltd (ASX:NTU), a heavy rare earths producer, has enhanced its Board of Directors by appointing Adam Handley as a non-executive director, effective immediately. Click here Sovereign Metals Limited (ASX:SVM) shares will be admitted to the AIM market of the London Stock Exchange (AIM) at 8am (GMT) today while retaining its ASX listing. Click here Nova Minerals Ltd (ASX:NVA, OTCQB:NVAAF) majority-owned Snow Lake Resources has been cleared to start its winter drilling campaign at the Thompson Brothers Lithium Project in Manitoba, Canada. Click here Kingston Resources Ltd (ASX:KSN) shareholders have today given the green light to the acquisition...

FTI Consulting to Acquire BOLD

Written by Customer Service on December 14, 2021. Posted in Mergers And Acquisitions.

Leading Restructuring, Transactions, Digital and Transformation Advisory Firm Enhances FTI Consulting’s Footprint in Continental Europe with Presence in the Netherlands WASHINGTON, Dec. 14, 2021 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that it has entered into a definitive agreement to acquire BOLD, a leading restructuring, transactions, digital and transformation advisory firm in the Netherlands. The acquisition is expected to close during the first quarter of 2022. Terms of the transaction were not disclosed. Founded in 2013 by Klaas Wagenaar and Gerrit van Munster, BOLD helps businesses become and stay relevant and successful in times of strategic change and mergers and acquisitions. The acquisition will extend FTI Consulting’s restructuring, business transformation, digital and transactions teams...

At 8.3% CAGR, PCR Market Size [2021-2028] To Hit USD 8.14 Billion – Fortune Business Insights

Written by Customer Service on December 14, 2021. Posted in Mergers And Acquisitions.

Key Companies in PCR Market are Agilent Technologies, Inc., Qiagen, Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Sysmex Inostic, Abbott, Thermo Fischer Scientific Inc., Eppendorf AG, Other players Pune, India, Dec. 14, 2021 (GLOBE NEWSWIRE) — PCR Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast latest study published by Fortune Business Insights. The global “PCR Market” is expected to reach USD 8.14 billion by 2026, on account of the advent of digitalization and the gradual shift from traditional PCR to digital PCR for diagnostics purposes. PCR is considered the most unique and most widely referred clinical testing technique utilized in modern biology. It includes a molecular technology...

Valoe Prepares to Increase Its Activities in Vipv Business. Valoe Draws Down 750,000 Euro From Riverfort.

Written by Customer Service on December 14, 2021. Posted in Public Companies.

Valoe Corporation Stock Exchange Release 14 December 2021 at 10.00 Finnish time As announced on 30 July 2021, Valoe Corporation (“Valoe”) and RiverFort Global Opportunities PCC Limited (“RiverFort”) signed a funding agreement on a three (3) year financing facility of up to EUR 30 million (“Financing Facility”). Now, Valoe raises EUR 750,000 pursuant to the terms and conditions of the Financing Facility. Valoe CEO Iikka Savisalo: Valoe has several customer projects related to VIPV (Vehicle Integrated Photovoltaics) business. We are preparing to increase our activities within this business sector, and RiverFort provides a flexible source of cash for working capital during the development stage of Valoe’s offering to the automotive industry. Following the drawdown of the Third Advance Valoe will grant 2,224,199 warrants to...

On substantial participation (2)

Written by Customer Service on December 14, 2021. Posted in Public Companies.

On December 10th, 2021 JSC Olainfarm has received announcement on substantial participation from SIA OLMAFARM. According to the announcement share of voting rights has decreased from 28.37% to 0%. The received announcement (in Latvian) is attached.Additional information: Jānis LeimanisJSC Olainfarm Member of the Management BoardTel. +371 29269424E-pasts: janis.leimanis@olainfarm.comAttachmentPazinojums_lidz.zaud.Olmafarm_10.12.2021

Mainz Biomed Expands ColoAlert Commercialization with GANZIMMUN Diagnostics in Europe

Written by Customer Service on December 14, 2021. Posted in Public Companies.

Mainz to co-brand ColoAlert with GANZIMMUN Diagnostics, one of the largest stool analysis labs in GermanyGANZIMMUN Diagnostics has an interdisciplinary team of over 370 medical technical assistants, physicians, chemists, biologists, and nutritionists who process approximately 5,500 laboratory orders dailyBERKELEY, Calif. and MAINZ, Germany, Dec. 14, 2021 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a partnership with leading diagnostics laboratory GANZIMMUN Diagnostics AG (GD), one of Europe’s leading laboratories for preventive and complementary medicine, for the commercialization in Germany of ColoAlert, Mainz’s unique, highly efficacious, and easy-to-use detection test for...

Air Liquide and IVECO collaborate to accelerate the development of hydrogen heavy-duty mobility in Europe

Written by Customer Service on December 14, 2021. Posted in Public Companies.

London, UK, and Paris, FR, December 14, 2021 IVECO, the commercial vehicles brand of CNH Industrial (NYSE: CNHI / MI: CNHI), and Air Liquide, a world leader in gases, technologies and services for Industry and Health, have signed a Memorandum of Understanding to develop hydrogen mobility in Europe. The partnership will contribute to materialize clean mobility by leveraging the two companies’ complementary competencies, in particular Air Liquide’s unique expertise across the entire hydrogen value chain, from production and storage to distribution, and IVECO’s legacy as a provider of advanced, clean sustainable transport solutions. Both partners will dedicate means and resources to study the roll-out of heavy-duty fuel-cell electric long-haul trucks coupled with the deployment of a network of renewable or low-carbon hydrogen refuelling...

Year: 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals